Dermira vets license back candidates from Eli Lilly to launch their own upstart

Retrieved on: 2021-01-07 14:35:05

Tags for this article:

Click the tags to see associated articles and topics

Dermira vets license back candidates from Eli Lilly to launch their own upstart. View article details on hiswai:

Excerpt

Lilly had its sights set on lebrikizumab, a cast-off from Roche that Dermira picked up for $135 million in near-term cash. But Dermira was also focused ...

Article found on: endpts.com

View Original Article